Alessandro is co-founder and Head of Research of Syntropic Medical, where he spearheads research advancements, drawing on his extensive experience in Neurophysiology. 

He studied Biomedicine at the University of Pavia (Italy) and during his thesis, he performed electrophysiology and neuronal network modeling in the vestibular system. Afterward, he obtained a Ph.D. in Cellular and Molecular Neurophysiology at the University of Pavia working on the role of microglia in the central auditory pathway. He then moved to the Institute of Science and Technology Austria (ISTA), in the group of Prof. Siegert as a research scientist. At ISTA he is applying advanced imaging and electrophysiology techniques to study how microglia interact with neurons in healthy and pathological conditions. His study about microglia response to ketamine and pulsed light was selected by the Society for Neuroscience (SfN) as one of the 100 hot topics in neuroscience 2019. He was a visiting scientist at Femtonics/Hungarian Academy of Science (Budapest, Hungary) and at the Massachusetts Institute of Technology (MIT) (Cambridge, USA).

In 2023 he co-founded Syntropic Medical, where he is the Head of Research.

• 

  Co-Founder and Head of Research in Syntropic

  Syntropic develops novel new treatments for psychiatric disorders.